Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Rocket Pharmaceuticals, Inc. RCKT

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$0
$-223.1M
$-190.5M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 0.00
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.0 · Net income -223.1
-100M-200M
20142017202020232025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE
FY2025 · ROE -60.3%
-50%-100%-150%
201420192025
Three returns, three denominators.

Each USD of equity lost 60 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -190.5
-100M-200M
201420192025
Net buybacks $M Dividends $M
FY2021 · Dividends · · Net buybacks -11.3
-100M-200M
201620172018201920202021

Total assetsUSD 330.4M
EquityUSD 277.2M
CashUSD 77.6M
Current ratio6.38×

Equity funds 84% of total assets.

The 12-year record

12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
RCKT, 12-year financial record
Metric 202520242023202220212020201920182017201620152014
Revenue $B0.00.00.00.00.00.00.00.00.00.0◌◌
Operating income $B−0.2−0.3−0.3−0.2−0.2−0.1−0.1−0.1−0.0−0.0−0.0−0.0
EBITDA $B−0.2−0.3−0.3−0.2−0.2−0.1−0.1−0.1−0.0−0.0−0.0−0.0
Income tax $B0.00.00.0◌◌◌◌◌◌◌◌◌
Net income $B−0.2−0.3−0.2−0.2−0.2−0.1−0.1−0.1−0.0−0.0−0.1−0.0
Free cash flow $B−0.2−0.2−0.2−0.2−0.1−0.1−0.1−0.1−0.0−0.0−0.0◌
EPS, diluted $−2.01−2.73−2.92−3.26−2.67−2.52−1.58−1.89−2.88−1.11−3.72−13.52
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————
ROE %−60.3−54.1−50.0−47.0−35.3−34.5−30.8−71.1−163.9−63.3——
Shares out B0.110.110.090.080.060.060.050.050.010.030.030.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 12 of the 12 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. Seven checks were skipped: EPS is not tagged before 2014.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2014

Share this section

Download image